Hannover Rück stock trades firm as reinsurer lifts dividend after strong 2024 earnings
Published on 07/31/2026 at 18:26 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Hannover Rück stock is underpinned by the German reinsurer's stronger 2024 earnings and an increased dividend that highlight the group's capital strength and demand for reinsurance cover. According to the annual reporting for fiscal 2024 published in March 2025, Hannover Rück (ISIN DE0008402215) grew its net income and proposed a higher payout to shareholders, reinforcing its position as one of the largest global reinsurers by premium volume.
Net income rises and dividend increases
In its annual report for fiscal 2024, Hannover Rück reported group net income of around EUR 2.15 billion, up from approximately EUR 1.8 billion in 2023, reflecting an increase of roughly 19% year on year, according to figures presented in its investor information. The company attributed this improvement to continued growth in its reinsurance book, favorable pricing in property and casualty lines, and disciplined underwriting in both primary and specialty segments.
On the back of these earnings, Hannover Rück proposed raising the total dividend for fiscal 2024 to about EUR 6.00 per share, compared with approximately EUR 5.50 per share for fiscal 2023, implying an increase of around 9% year on year for investors who hold the stock as of the relevant record date. The combination of rising net income and a higher dividend payout ratio illustrates how management is using its capital position to reward shareholders while still retaining sufficient funds to support future growth and regulatory capital requirements.
Gross written premium volumes also expanded in 2024. According to the same reporting set, Hannover Rück generated roughly EUR 35.0 billion in gross written premiums in fiscal 2024, compared with around EUR 32.3 billion in 2023, an increase of about 8% year on year. This growth resulted from rate hardening in property catastrophe reinsurance, additional treaty business in life and health reinsurance, and selective expansion in specialty lines such as agriculture and structured reinsurance solutions. For investors, the premium growth signals continued demand from cedents seeking capacity and risk transfer, which supports the earnings outlook if claims environments remain manageable over time.
Return on equity and combined ratio support stock appeal
Hannover Rück's profitability metrics provide additional context for the stock. For fiscal 2024, the reinsurer reported a return on equity of roughly 15% based on its IFRS financial statements, compared with around 13% in 2023, indicating an improvement of about 2 percentage points. This uplift reflects the stronger net income combined with a stable equity base, and aligns with management's long term ambition for double digit returns despite market volatility and large loss events.
In the property and casualty reinsurance segment, Hannover Rück achieved a combined ratio of approximately 93% in fiscal 2024, slightly better than the roughly 94% level in 2023. A combined ratio below 100% means the underwriting business remains profitable before investment income, and the improvement underscores the reinsurer's disciplined risk selection and pricing in the face of natural catastrophe exposures and claims inflation. For investors comparing global reinsurers, such a mid ninety percent combined ratio places Hannover Rück broadly in line with international peers, while the company aims to preserve this discipline across cycles.
Life and health reinsurance also contributed to earnings. For fiscal 2024, segment results show operating profit in life and health reinsurance of around EUR 900 million, up from approximately EUR 800 million in 2023, representing growth of roughly 12.5% year on year. The performance reflects demand for longevity risk transfer, biometric covers, and financial solutions that help cedents manage capital and solvency requirements. This diversification between property and casualty lines and life and health business supports the resilience of Hannover Rück's overall earnings, which is a key consideration for long term shareholders.
Capital position and solvency metrics
Hannover Rück's capital position under European Solvency II rules is another factor underpinning Hannover Rück stock. In its latest solvency and financial condition report for 2024, the reinsurer disclosed a Solvency II ratio near 220%, well above the 100% regulatory minimum and within its target range. This ratio measures eligible own funds relative to the prescribed solvency capital requirement and provides a quantitative indicator of resilience against adverse events. The level above 200% confirms that Hannover Rück operates with a comfortable buffer, enabling it to absorb potential large losses while maintaining the ability to pay dividends and pursue growth opportunities.
The company's financial flexibility is also visible in its debt profile. According to investor information for 2024, Hannover Rück reported a financial leverage ratio in the mid twenty percent range, based on hybrid and senior debt compared with total capital. This moderate leverage is typical for global reinsurers and allows the company to optimize its cost of capital while preserving headroom for further issuance if necessary. Rating agencies, which assess Hannover Rück's ability to honor obligations, generally view such leverage and solvency metrics favorably, contributing to stable ratings that are important when placing reinsurance programs with cedents.
Investment income remains a complementary earnings driver. In fiscal 2024, Hannover Rück recorded net investment income of roughly EUR 2.0 billion, up from around EUR 1.7 billion in 2023, an increase of almost 18%. The growth reflects higher yields on fixed income portfolios as interest rates remained elevated compared with the ultra low environment of previous years, as well as disciplined risk management across credit and duration exposures. For shareholders, the higher investment income provides a buffer during years with elevated claims and strengthens the overall profitability profile.
Premium growth and market environment
Hannover Rück operates in a global reinsurance market that has experienced several years of rate improvements following heavy loss activity from natural catastrophes and pandemic related claims. As cedents seek to protect their balance sheets against volatility, they have accepted higher reinsurance prices and tighter conditions, which benefits disciplined reinsurers such as Hannover Rück. The company's gross written premiums of roughly EUR 35.0 billion in fiscal 2024 reflect this environment and suggest ongoing demand for property catastrophe covers, proportional treaties, and specialty risk solutions.
In property catastrophe reinsurance, Hannover Rück has focused on maintaining underwriting discipline by limiting exposure to peak zones and employing sophisticated catastrophe modeling. The mid ninety percent combined ratio in fiscal 2024 indicates that, despite events such as hurricanes and severe convective storms, the reinsurer kept its catastrophe losses within tolerances. For investors, the key question is whether this underwriting approach can continue delivering returns as climate related risks evolve and as cedents and regulators scrutinize insurers' risk modeling assumptions more closely.
In life and health reinsurance, Hannover Rück has been active in longevity swaps, mortality covers, and financial solutions that help life insurers manage capital requirements under Solvency II and similar frameworks. The operating profit of around EUR 900 million in fiscal 2024 from this segment reflects the contribution of these solutions in a market characterized by aging populations and demand for insurance products that transfer biometric risks. This diversification means that earnings are not solely dependent on natural catastrophe exposures, which can be volatile from year to year.
Guidance and outlook signals
Management has provided guidance for future earnings and dividends. In its outlook for fiscal 2025, Hannover Rück indicated a target group net income of around EUR 2.2 billion, slightly above the EUR 2.15 billion achieved in 2024, assuming a large loss budget consistent with recent years and a continuation of favorable pricing conditions. This guidance, while subject to uncertainty, suggests that the company expects to maintain or modestly grow its profitability despite potential macroeconomic and risk related challenges.
Hannover Rück also aims to maintain an attractive dividend policy. The increase to about EUR 6.00 per share for 2024 dividends compared with roughly EUR 5.50 for 2023 demonstrates management's willingness to share earnings growth with shareholders while keeping flexibility to adjust payouts if claims or regulatory developments require. Investors often evaluate such policies in comparison with other European reinsurers to assess total return potential from income and capital gains.
For the medium term, Hannover Rück has indicated in various investor communications that it seeks to sustain a return on equity in the low to mid teens under normal market conditions. Achieving the approximately 15% ROE reported for 2024 therefore aligns with these ambitions and supports the narrative that the reinsurer's business mix and risk management approach can deliver attractive returns over the cycle. However, as with all reinsurance businesses, results are subject to variability from large losses, changes in interest rates, regulatory shifts, and competition.
Product segment Reinsurance solutions
In its reinsurance solutions business, Hannover Rück offers structured covers and alternative risk transfer arrangements designed to meet specific cedent needs, including capital relief and earnings smoothing. These solutions are part of the broader specialty lines portfolio and have contributed to the measured growth in gross written premiums during fiscal 2024 and prior years. By tailoring reinsurance structures that align with clients' regulatory and rating agency requirements, Hannover Rück aims to deepen relationships and differentiate itself from competitors that focus more narrowly on traditional treaty structures.
Such products often require sophisticated modeling and an understanding of regulatory frameworks in multiple jurisdictions. Hannover Rück's ability to craft solutions across life and non life segments positions it as a partner for insurers seeking to manage complex risks and capital constraints. For shareholders, the growth of these structured solutions indicates that the reinsurer is not only relying on standard reinsurance covers but is also leveraging its expertise to build higher value added offerings that can support margins over time.
Hannover Rück stock price context
Hannover Rück stock is listed on Xetra under the ticker XETRA: HNR1, making it accessible to investors who focus on German and European insurance and reinsurance equities. As of 30 June 2025, the shares traded at around EUR 220 on Xetra, according to data from German market portals. At that level, the price was close to the upper part of the 52 week trading range, which spanned roughly from EUR 185 to EUR 225 over the prior year.
At the price of about EUR 220 as of 30 June 2025, Hannover Rück's market capitalization stood near EUR 26 billion based on outstanding shares disclosed in its investor information. The proximity of the share price to the top of the 52 week range reflects investor confidence in the company's earnings trajectory, capital position, and dividend policy following the stronger 2024 results. For shareholders, the combination of a higher dividend and a share price at elevated levels suggests that much of the recent earnings improvement may already be reflected in valuations, though ongoing premium growth and disciplined underwriting remain key drivers.
Over the preceding twelve months to 30 June 2025, Hannover Rück stock delivered a total shareholder return that combined capital gains from the share price moving from roughly EUR 190 to around EUR 220 and dividend distributions. While this performance must be compared with indices such as the DAX and sector peers, it underscores that the market has responded positively to the reinsurer's improved net income, higher dividends, and strong solvency metrics.
Hannover Rück stock key data
- Company: Hannover Rück SE
- ISIN: DE0008402215
- WKN: 840221
- Ticker: XETRA: HNR1
- Trading venue: Xetra
- Price (as of 30 June 2025, 16:30 CET): 220 EUR
- Market capitalization: 26,000,000,000 EUR (as of 30 June 2025)
- Sector / Industry: Financials / Reinsurance
- Index membership: MDAX
- Next earnings date: 12 March 2026
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
